RETRACTABLE TECHNOLOGIES, INC.

Retractable Technologies, Inc. (RTI) is a publicly traded medical device manufacturer headquartered in Little Elm, Texas, specializing in safety-engineered needle products with automated retraction technology. Founded in 1994, RTI designs, manufactures, and distributes innovative solutions focused on preventing needlestick injuries and reducing bloodborne pathogen exposure in healthcare settings. The company's flagship VanishPoint® technology features automatic needle retraction activated by a single-handed, passive mechanism requiring no additional steps. RTI's comprehensive product portfolio includes safety syringes in various sizes, VanishPoint U-100 insulin syringes, EasyPoint retractable needles, blood collection devices with tube holders, and VanishPoint IV catheters. All products incorporate low dead space technology to reduce medication waste. RTI's solutions are trusted by eight of the top ten U.S. hospitals and deployed across 15,150+ healthcare facilities globally. The company emphasizes clinical safety, operational efficiency, cost reduction through medication and disposal savings, and environmental sustainability. RTI has supplied over 1.2 billion syringes for COVID-19 immunization campaigns worldwide.